Together these data provide new insights into the phenotype of Mtb-specific CD4 T cells in the setting of co-infection with Mtb and HIV and provide rationale for future studies to evaluate the utility of targeting BTLA and HVEM signaling pathways to enhance protective immunity to Mtb. This evidence concerns the gene BTLA and coinfection.